Thymic Stromal Lymphopoietin (TSLP) in Vitiligo

Cairo University (CU)

Status: Completed

Conditions: Vitiligo

Treatments: Other: skin biopsy

Study type: Interventional

Funder types: Other

Identifiers

NCT03367273

Dermatology 2

Details and patient eligibility

About

study & verify the hypothesis of the involvement of TSLP in the pathogenesis of vitiligo in comparison to their levels in the healthy control persons.

Enrollment: 50 patients

Sex: All

Ages: 18+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• • Patients with generalized non-segmental vitiligo.

  • Both sexes.
  • Age < 18 years old age.
  • New cases or cases not receiving any medication for at least 3 months ago.

Exclusion criteria

• • Age: Patients < 18 years.

  • Segmental or universal vitiligo.
  • Pregnant and lactating females. Autoimmune diseases

Trial design

Primary purpose: Health Services Research

Allocation: Non-Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

50 participants in 2 patient groups

vitiligo patients

Experimental group

Treatment:

Other: skin biopsy

controls

Experimental group

Treatment:

Other: skin biopsy